ArticleCurrent oncology (Toronto, Ont.)2024

Inflammatory Mesenteric Disease and Sarcoidosis-like Reaction in a Patient with Lung Adenocarcinoma Who Received Pembrolizumab: Paraneoplastic Syndrome, Secondary to Checkpoint Inhibitor or Chance Finding?

Luis Posado-Domínguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.